Rekha Hemrajani - 10 Sep 2025 Form 3 Insider Report for LB PHARMACEUTICALS INC

Role
Director
Signature
/s/ Marc Panoff, Attorney-in-Fact
Issuer symbol
LBRX on Nasdaq
Transactions as of
10 Sep 2025
Net transactions value
$0
Form type
3
Filing time
10 Sep 2025, 19:30:17 UTC
Previous filing
27 Aug 2025
Next filing
21 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hemrajani Rekha Director C/O LB PHARMACEUTICALS INC, ONE PENNSYLVANIA PLAZA, SUITE 1025, NEW YORK /s/ Marc Panoff, Attorney-in-Fact 10 Sep 2025 0001771213

No securities are beneficially owned.